Table 1.
Clinical characteristics of six patients with CRKp infection in EICU.
| No. | Gender | Age | Clinical diagnosis | CRKp derived specimens | Antibiotic therapy | Admission date | Discharge date | Traumatic treatment | Prognosis |
|---|---|---|---|---|---|---|---|---|---|
| P1 | F | 86 | Severe pneumonia | BALF | MEM, SCF,TGC | 2019/2/3 | 2019/3/4 | Bronchoscope | Got better |
| P2 | M | 66 | Septic shock | Blood, Sputum, BALF | TZP, MFX, VRC, LEV, TGC, SCF | 2019/2/1 | 2019/2/17 | Respirator, Bronchoscope, PICC | Death |
| P3 | F | 85 | COPD | Sputum | N | 2019/2/15 | 2019/2/20 | Respirator, Urinary catheter | Death |
| P4 | M | 81 | Severe pneumonia | Blood, Sputum | TZP, LEV, SCF, TGC | 2019/1/19 | 2019/2/28 | Respirator, Gastric tube | Gave up |
| P5 | M | 77 | COPD | Sputum | LEV, SCF, TGC | 2019/2/12 | 2019/3/11 | Respirator | Got better |
| P6 | M | 60 | Cerebral infarction | Blood, Sputum, BALF | TZP, TGC | 2019/2/16 | 2019/2/26 | Respirator, Urinary catheter, PICC | Death |
F, female; M, man; N, no; COPD, Chronic obstructive pulmonary disease; BALF, Bronchoalveolar lavage fluid; MEM, meropenem; SCF, cefoperazone/sulbactam; TGC, tigecycline; TZP, piperacillin-tazobactam; MFX, moxifloxacin; VRC, voriconazole; LEV, levofloxacin; PICC, peripherally inserted central venous catheter.